← Leaderboards
Jian None Liu
University Of North Carolina Chapel Hill
$13,658,713
Attributed
$20,631,519
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,281,521 · 12
FDA$1,349,998 · 1
By mechanism
R01$14,551,828 · 7
RF1$2,595,120 · 1
U19$1,349,998 · 1
U01$1,164,996 · 1
R41$521,444 · 2
R21$448,133 · 1
Top collaborators
- Ding Xu9 shared
- Robert J Linhardt6 shared
- Paul L Deangelis4 shared
- Rafal L Pawlinski4 shared
- Chunyu Wang4 shared
- Lianchun Wang4 shared
- Pyong Woo Park2 shared
Others in their field
Top investigators on “Oligosaccharides”
- Dennis L. Kasper · Harvard Medical School$27,868,053
- Geert-Jan Boons · University Of Georgia (Uga)$16,473,058
- Jacques U Baenziger · Washington University$12,267,027
- Ajit P Varki · University Of California San Diego$11,487,386
- Wayne Lencer · Children'S Hospital Boston$11,480,415
- Hien M Nguyen · University Of Iowa$10,731,228
Research focus
OligosaccharidesPolysaccharidesHeparitin SulfateStructureBaseIn VitroDesignCell SurfaceSulfotransferaseHeparinPatternEnzymesUnspecified Or Sulfate Ion SulfatesExtracellular MatrixSeriesLeadAnticoagulantsModificationPharmaceutical PreparationsInorganic SulfatesPlayBinding SitesCellsRecombinants
Grant awards (57)
ApoE and Heparan Sulfate Interaction in Alzheimerâs Disease$732,702
R01 · FY2025 · AG
The role of heparan sulfate in cathepsin K biology$519,450
R01 · FY2025 · DE
ApoE and Heparan Sulfate Interaction in Alzheimerâs Disease$782,087
R01 · FY2024 · AG
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease$554,778
R01 · FY2024 · AG
The role of heparan sulfate in cathepsin K biology$528,793
R01 · FY2024 · DE
The role of heparan sulfate in cathepsin K biology$1
R01 · FY2024 · DE
The role of heparan sulfate in cathepsin K biology$539,586
R01 · FY2023 · DE
The role of heparan sulfate in cathepsin K biology$554,586
R01 · FY2022 · DE
In vitro synthesis of recombinant heparan sulfate$463,744
R01 · FY2021 · HL · contact PI
Synthesis and Pharmacological Evaluation of Homogenous Ultra-Low Molecular Weight Heparins$306,242
R01 · FY2021 · HL · contact PI
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease$2,595,120
RF1 · FY2020 · AG
In vitro synthesis of recombinant heparan sulfate$465,717
R01 · FY2020 · HL · contact PI
Synthesis and Pharmacological Evaluation of Homogenous Ultra-Low Molecular Weight Heparins$306,241
R01 · FY2020 · HL · contact PI
In vitro synthesis of recombinant heparan sulfate$469,439
R01 · FY2019 · HL · contact PI
Synthesis and Pharmacological Evaluation of Homogenous Ultra-Low Molecular Weight Heparins$333,991
R01 · FY2019 · HL · contact PI
In vitro synthesis of recombinant heparan sulfate$485,396
R01 · FY2018 · HL · contact PI
Developing Heparan Sulfate Glycan Array$146,845
R41 · FY2018 · GM · contact PI
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP$300,000
U19 · FY2017 · FD · contact PI
Development of a New Carbohydrate-based Anticoagulant Drug$224,698
R41 · FY2017 · HL · contact PI
Developing Heparan Sulfate Glycan Array$149,901
R41 · FY2017 · GM · contact PI
In vitro synthesis of recombinant heparan sulfate$456,016
R01 · FY2016 · HL · contact PI
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs$389,112
R01 · FY2016 · HL
Uncovering the controlling mechanisms in heparan sulfate biosynthesis$284,749
U01 · FY2016 · GM · contact PI
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP$250,001
U19 · FY2016 · FD · contact PI
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP$49,999
U19 · FY2016 · FD · contact PI
In vitro synthesis of recombinant heparan sulfate$437,995
R01 · FY2015 · HL · contact PI
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs$383,385
R01 · FY2015 · HL
Uncovering the controlling mechanisms in heparan sulfate biosynthesis$284,749
U01 · FY2015 · GM · contact PI
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP$249,999
U19 · FY2015 · FD · contact PI
In vitro synthesis of recombinant heparan sulfate$26,880
R01 · FY2015 · HL · contact PI
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs$381,547
R01 · FY2014 · HL
In vitro synthesis of recombinant heparan sulfate$374,845
R01 · FY2014 · HL · contact PI
Uncovering the controlling mechanisms in heparan sulfate biosynthesis$284,749
U01 · FY2014 · GM · contact PI
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP$249,999
U19 · FY2014 · FD · contact PI
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs$419,533
R01 · FY2013 · HL
In vitro synthesis of recombinant heparan sulfate$390,190
R01 · FY2013 · HL · contact PI
Uncovering the controlling mechanisms in heparan sulfate biosynthesis$310,749
U01 · FY2013 · GM · contact PI
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP$250,000
U19 · FY2013 · FD · contact PI
In vitro synthesis of recombinant heparan sulfate$399,536
R01 · FY2012 · HL · contact PI
In vitro synthesis of recombinant heparan sulfate$407,650
R01 · FY2011 · HL · contact PI
In vitro synthesis of recombinant heparan sulfate$423,870
R01 · FY2010 · HL · contact PI
Structural Specificity of Heparan Sulfate for Herpes Infections$325,744
R01 · FY2010 · AI · contact PI
Glycomics of Heparan Sulfate in Bacterial Pathogenesis$197,258
R21 · FY2010 · AI · contact PI
Structural Specificity of Heparan Sulfate for Herpes Infections$7,459
R01 · FY2010 · AI · contact PI
Structural Specificity of Heparan Sulfate for Herpes Infections$429,463
R01 · FY2009 · AI · contact PI
In vitro synthesis of recombinant heparan sulfate$377,776
R01 · FY2009 · HL · contact PI
Glycomics of Heparan Sulfate in Bacterial Pathogenesis$250,875
R21 · FY2009 · AI · contact PI
In vitro synthesis of recombinant heparan sulfate$45,961
R01 · FY2009 · HL · contact PI
Structural Specificity of Heparan Sulfate for Herpes Infections$280,676
R01 · FY2008 · AI · contact PI
Structural Specificity of Heparan Sulfate for Herpes Infections$45,916
R01 · FY2008 · AI · contact PI
Structural Specificity of Heparan Sulfate for Herpes Infections$286,113
R01 · FY2007 · AI · contact PI
Structural Specificity of Heparan Sulfate for Herpes Infections$306,158
R01 · FY2006 · AI · contact PI
SPECIFICITY OF HEPARAN SULFATE FOR HERPES INFECTION$217,082
R01 · FY2004 · AI
SPECIFICITY OF HEPARAN SULFATE FOR HERPES INFECTION$36,366
R01 · FY2004 · AI
SPECIFICITY OF HEPARAN SULFATE FOR HERPES INFECTION$217,082
R01 · FY2003 · AI
SPECIFICITY OF HEPARAN SULFATE FOR HERPES INFECTION$217,082
R01 · FY2002 · AI
SPECIFICITY OF HEPARAN SULFATE FOR HERPES INFECTION$225,638
R01 · FY2001 · AI